Clinical Research Advantage, Inc. Introduces Services in Colorado Springs, Colorado
<~-- -->
Clinical Research Advantage, Inc.
, (CRA), a provider of a range of research services to pharmaceutical companies and clinical research organizations (CROs), announced its expansion into the Colorado Springs market with the opening of two local area offices.
CRA has forged a partnership with a medical practice in the area whose physicians serve as principal investigators of the clinical trials it manages and oversees. As a trial management organization (TMO), CRA helps clinical trial sponsors bring drugs to market more quickly and efficiently. CRA offers a mechanism for medical professionals to conduct phase II-IV clinical research trials. CRA is comprised of dozens of community-based investigators based throughout the country.
Local CRA offices in Colorado Springs include one at Colorado Springs Health Partners in Briargate—2405 Research Parkway in Briargate (office of Kari Uusinarkaus, M.D.; Dennis Schneider, M.D. and Gordon Golden, M.D.); and on the east side at 6340 Barnes Road (office of John Speer, M.D., Max Nevarez, M.D., Royce Solano, M.D. and Alan Garscadden, M.D.).
Current plans call for several more sites to open in the Colorado Springs area by summer 2011.
The new offices and principal investigators focus on trials and maintenance studies relating to the various diagnoses as well as others within the realm of family and internal medicine. At Briargate, studies underway include irritable bowel syndrome-diarrhea, hypercholesterolemia, Type II Diabetes Naïve (not currently being treated with anti-diabetic medication) and acute coronary syndrome with or without Type II Diabetes. Upcoming studies include Type II Diabetes and hypertriglyceridemia. At the east office, studies being conducted include those for chronic obstructive pulmonary disease, irritable bowel syndrome-diarrhea, pediatric influenza vaccine, and Type II Diabetes with cardiovascular risk. Upcoming studies at this office include opioid-induced constipation and Type II diabetes.
Concurrent with the office openings, CRA named Monica Garcia, BS, CCRC, to the post of region manager. Garcia heads the Colorado Springs-area operations and has worked with CRA for the past six years. She is certified through the Association of Clinical Research Professionals , an industry trade organization that serves as a resource for clinical research professionals engaged in the pharmaceutical, biotechnology and medical device industries, and those in hospital, academic medical centers and physician office settings.
Since CRA was acquired in 2007 by Mark Hanley, who serves as chief executive officer, and David Bruggeman, president and chief operating officer, the company has grown from six to 23 sites, doubled the number of employees and substantially increased the revenue base.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
